We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

138 hedge funds and large institutions have $85.3M invested in Nektar Therapeutics in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 47 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $79.3M → $85.3M (+$5.99M)

0.17% more ownership

Funds ownership: 4.86% → 5.02% (+0.17%)

5% less funds holding

Funds holding: 146 → 138 (-8)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

32% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 47

52% less call options, than puts

Call options by funds: $23K | Put options by funds: $48K

Holders
138
Holders Change
-8
Holders Change %
-5.48%
% of All Funds
2.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
32
Reduced
47
Closed
23
Calls
$23K
Puts
$48K
Net Calls
-$25K
Net Calls Change
-$300K

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$12M
2
TCM
Tang Capital Management
California
+$2.44M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.07M
4
Marshall Wace
Marshall Wace
United Kingdom
+$1.88M
5
LCM
Lynx1 Capital Management
Puerto Rico
+$1.13M

Top Sellers

1
SCM
Sio Capital Management
New York
-$4.02M
2
Invesco
Invesco
Georgia
-$3.32M
3
MAM
Monaco Asset Management
Monaco
-$2.86M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.62M
5
Millennium Management
Millennium Management
New York
-$2.11M
Name Holding Trade Value Shares
Change 		Change in
Stake
MWM
101
Maltin Wealth Management
New Jersey
$7.74K – – –
CA
102
Cetera Advisors
Colorado
$7.56K -$2.94K -305 -26%
ProShare Advisors
103
ProShare Advisors
Maryland
$7.4K +$125 +13 +2%
IC
104
IEQ Capital
California
$6.91K – – –
RWA
105
Ropes Wealth Advisors
Massachusetts
$6.9K – – –
Neuberger Berman Group
106
Neuberger Berman Group
New York
$6.8K +$760 +79 +12%
Simplex Trading
107
Simplex Trading
Illinois
$6K +$2.25K +234 +49%
HPWA
108
Hall Private Wealth Advisors
North Carolina
$5.96K +$6.42K +667 New
CSS
109
Cubist Systematic Strategies
Connecticut
$3.86K -$10.9K -1,132 -72%
RhumbLine Advisers
110
RhumbLine Advisers
Massachusetts
$3.17K -$5.59K -581 -62%
Wells Fargo
111
Wells Fargo
California
$3.08K -$2.25K -234 -40%
CUAMC
112
China Universal Asset Management Company
China
$2.91K +$1.54K +160 +97%
S
113
SignatureFD
Georgia
$1.91K – – –
BBHC
114
Brown Brothers Harriman & Co
New York
$1.7K – – –
CWM
115
Compass Wealth Management
Connecticut
$1.19K – – –
NA
116
NewEdge Advisors
Louisiana
$1.13K – – –
CG
117
Cutler Group
California
$1K – – –
Federated Hermes
118
Federated Hermes
Pennsylvania
$998 -$478K -49,706 -100%
FCMT
119
Founders Capital Management (Texas)
Texas
$893 – – –
VCM
120
Versant Capital Management
Arizona
$448 – – –
ACA
121
Atlas Capital Advisors
Wyoming
$357 – – –
PP
122
PFS Partners
New Jersey
$356 – – –
First Manhattan
123
First Manhattan
New York
$297 – – –
PWMG
124
Provence Wealth Management Group
California
$208 +$221 +23 New
National Bank of Canada
125
National Bank of Canada
Quebec, Canada
$187 – – –
3 4
5
6 7

NKTR Hedge Fund Activity: Q3 2023 in Review

138 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q3 2023, worth a combined $85.3M — up 7.6% from $79.3M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of NKTR and 16 opened new positions — a net loss of 7 holders — while 47 trimmed existing stakes and 32 added.

The largest buyer was RA Capital Management, opening a new position worth an estimated $12M. The largest seller was Sio Capital Management, exiting entirely with an estimated $4.02M sold.

  • 138 institutional investors held Nektar Therapeutics (NKTR) as of Q3 2023, down from 146 in Q2 2023.
  • Funds reported $85.3M of Nektar Therapeutics stock for Q3 2023, up 7.6% quarter-over-quarter.
  • 16 funds opened new Nektar Therapeutics positions in Q3 2023 and 23 closed out, a net change of -7 holders.
  • The largest Nektar Therapeutics buyer in Q3 2023 was RA Capital Management, an estimated $12M added.
  • The largest Nektar Therapeutics seller in Q3 2023 was Sio Capital Management, an estimated $4.02M sold.

Based on aggregated 13F filings for Q3 2023.